Lamia Dahdah

Dr. Lamia Dahdah


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2015 in Allergy
Verified
Journal Article
Closed access
PDF file
ASA. A. Schoemaker
A. A. Schoemaker
ASA. B. Sprikkelman
A. B. Sprikkelman
KGK. E. Grimshaw
K. E. Grimshaw
GRG. Roberts
G. Roberts
LGL. Grabenhenrich
L. Grabenhenrich
KBK. Beyer
K. Beyer

29 October 2015 in Allergy
Verified
Journal Article
Closed access
PDF file
PXP. Xepapadaki
P. Xepapadaki
AFAlessandro Fiocchi
Alessandro Fiocchi
LGL. Grabenhenrich
L. Grabenhenrich
GRG. Roberts
G. Roberts
KGK. E. C. Grimshaw
K. E. C. Grimshaw
KBK. Beyer
K. Beyer

23 December 2011 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
DMD. McBride
D. McBride
TKT. Keil
T. Keil
LGL. Grabenhenrich
L. Grabenhenrich
RDR. Dubakiene
R. Dubakiene
GDG. Drasutiene
G. Drasutiene
KBK. Beyer
K. Beyer

1 July 2019 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
AFAlessandro Fiocchi
Alessandro Fiocchi
MAMaria Cristina Artesani
Maria Cristina Artesani
CRCarla Riccardi
Carla Riccardi
MMMaurizio Mennini
Maurizio Mennini
VPValentina Pecora
Valentina Pecora
RVRocco Luigi Valluzzi
Rocco Luigi Valluzzi

1 November 2019 in World Allergy Organization Journal
Verified
Journal Article
Open access
EHElham Hossny
Elham Hossny
MEMotohiro Ebisawa
Motohiro Ebisawa
YEYehia El-Gamal
Yehia El-Gamal
SAStefania Arasi
Stefania Arasi
LDLamia Dahdah
Lamia Dahdah
AFAlessandro Fiocchi
Alessandro Fiocchi
Food allergy (FA) is currently a significant health care problem in the developing world. Widely varying study populations and methodologies, the use of surrogate markers such as self report or hospitalization rates due to anaphylaxis rather than objective methods, limits robust estimation of FA prevalence in low income settings. Also, allergy is under-recognized as a clinical specialty in the developing world which compromises the chance for accurate diagnosis. In this review, most published data on food allergens from developing or low income countries are displayed. The diagnostic challenges and limitations of treatment options are discussed. It seems that FA is an under-appreciated health care issue in the developing world, and accurate determination of its burden in low-income settings represents an important unmet need. Multicenter surveillance studies, using standardized methodologies, are, therefore, needed to reveal the true extent of the problem and provide epidemiological clues for prevention. Preventive strategies should be tailored to fit local circumstances in different geographic regions. In addition, studying the gene environment interactions and impact of early life microbiota on the expression of FA in developing communities would be worthwhile. Efforts and resources should be directed toward public health education and training of health care providers dealing with food allergic patients.

1 January 2016 in World Allergy Organization Journal
Verified
Journal Article
Open access
PDF file
AFAlessandro Fiocchi
Alessandro Fiocchi
LDLamia Dahdah
Lamia Dahdah
CDChristophe Dupont
Christophe Dupont
Cristina CampoyCristina Campoy
Cristina Campoy
VFVincenzo Fierro
Vincenzo Fierro
ANAntonio Nieto
Antonio Nieto
In 2010, the diagnosis and treatment of IgE-mediated CMA were systematized in a GRADE guideline. After 6 years, the state of the knowledge in diagnosis and treatment of CMA has largely evolved. We summarize here the main advances, and exemplify indicating some specific points: studies aimed at better knowledge of the effects of breastfeeding and the production of new special formulae intended for the treatment of CMA. The literature (PubMed/MEDLINE) was searched using the following algorithms: (1) [milk allergy] AND diagnosis; (2) [milk allergy] AND [formul*] OR [breast*], setting the search engine [6-years] time and [human] limits. The authors drew on their collective clinical experience to restrict retrieved studies to those of relevance to a pediatric allergy practice. Several clinical studies did address the possibility to diagnose CMA using new tools in vitro and in vivo, or to diagnose it without any evaluation of sensitization. Some studies also addressed the clinical role of formulae based on milk hydrolysates, soy, or rice hydrolysates in the treatment of CMA. Many studies have elucidated the effects of selective nutrients in breastfed infants on their immunologic and neurologic characteristics. Evidence-based diagnostic criteria should be identified for non-IgE-mediated CMA. Debate is ongoing about the best substitute for infants with CMA. In particular, Hydrolyzed Rice Formulae have been widely assessed in the last six years. In the substitute choice, clinicians should be aware of recent studies that can modify the interpretation of the current recommendations. New systematic reviews and metanalyses are needed to confirm or modify the current DRACMA recommendations.